AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 46 filers reported holding AVROBIO INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | -80.0% | 1,333 | -73.0% | 0.00% | – |
Q2 2022 | $5,000 | +150.0% | 4,928 | +296.8% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 1,242 | +148.4% | 0.00% | – |
Q4 2021 | $2,000 | -99.6% | 500 | -99.4% | 0.00% | – |
Q3 2021 | $468,000 | -48.3% | 83,837 | -17.8% | 0.00% | – |
Q2 2021 | $906,000 | -74.0% | 101,954 | -62.9% | 0.00% | – |
Q1 2021 | $3,490,000 | -55.9% | 275,054 | -51.5% | 0.00% | -100.0% |
Q4 2020 | $7,910,000 | +34.7% | 567,454 | +25.8% | 0.00% | 0.0% |
Q3 2020 | $5,874,000 | -56.7% | 451,154 | -41.9% | 0.00% | 0.0% |
Q2 2020 | $13,553,000 | +12.1% | 776,654 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $12,085,000 | +173.9% | 776,654 | +254.4% | 0.00% | – |
Q4 2019 | $4,412,000 | +159.4% | 219,170 | +82.0% | 0.00% | – |
Q3 2019 | $1,701,000 | -76.2% | 120,443 | -12.7% | 0.00% | -100.0% |
Q3 2018 | $7,153,000 | -49.9% | 137,900 | -72.4% | 0.00% | -50.0% |
Q2 2018 | $14,280,000 | – | 500,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,236,123 | $21,570,000 | 14.96% |
Aisling Capital Management LP | 1,009,779 | $17,621,000 | 6.72% |
Burrage Capital Management LLC | 225,900 | $3,942,000 | 2.76% |
New Leaf Venture Partners, L.L.C. | 315,550 | $5,506,000 | 1.58% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $13,960,000 | 1.36% |
Camber Capital Management LP | 1,350,000 | $23,558,000 | 1.35% |
Parkman Healthcare Partners LLC | 190,593 | $3,326,000 | 0.94% |
Eventide Asset Management | 1,905,307 | $33,248,000 | 0.72% |
Penn Mutual Asset Management | 37,306 | $651,000 | 0.66% |
EMERALD ADVISERS, LLC | 832,474 | $14,527,000 | 0.63% |